Substance Use Tools & Resources    

Explains whether opioid pain medications are safe for women who are pregnant or planning to become pregnant. Provides information about whether these patients should stop taking pain medication if they find out they are pregnant and whether breastfeeding women should continue medication.

Provides a comprehensive array of services, support, resources, and strategies to PDMPs, Federal partners, and other stakeholders to further the efforts and effectiveness of PDMPs in combating the misuse, abuse, and diversion of prescription drugs.

Presents an overview of PDMPs for prescribers.

By addressing the conditions that give rise to ACEs and simultaneously addressing the needs of children and parents, these strategies take a multi-generation approach to prevent ACEs and ensure safe, stable, nurturing relationships and environments.

Helps ensure patients who are beginning long-term therapy with opioid analgesics understand the side effects, risks, conditions, and purpose of their treatment. Facilitates clear communication between patients and healthcare providers about long-term opioid therapy, defines treatment expectations, and resolves any patient questions or concerns.

Provides patients with information about why opioid treatment can no longer be provided and information about local treatment programs.

Includes two sample patient agreement forms that can be used with patients who are beginning long-term treatment with opioid analgesics or other controlled substances. Helps ensure patients understand their role and responsibilities regarding their treatment and those of the healthcare providers, as well as the conditions under which their treatment may be terminated.

SCOPE of Pain is a series of continuing medical education/continuing nursing education activities designed to help you safely and effectively manage patients with acute and/or chronic pain, when appropriate, with opioid analgesics.

Offers continuing medical education/continuing nursing education activities, which help providers learn to safely and effectively manage patients with chronic pain, when appropriate, with opioid analgesics.

Supports face-to-face training to review results from research conducted by the NIDA CTN comparing detoxification with buprenorphine versus clonidine. Provides instruction for implementing this protocol in treatment settings, including methods of evaluation and induction, the taper schedule, and use of ancillary medications during treatment.